CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 77  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0842
LYS 10.0117
GLU 20.0197
LEU 30.0339
ARG 40.0286
CYS 50.0260
GLN 60.0127
CYS 70.0251
ILE 80.0538
LYS 90.0842
THR 100.0357
TYR 110.0189
SER 120.0158
LYS 130.0406
PRO 140.0188
PHE 150.0200
HIS 160.0220
PRO 170.0243
LYS 180.0360
PHE 190.0155
ILE 200.0099
LYS 210.0347
GLU 220.0236
LEU 230.0145
ARG 240.0142
VAL 250.0095
ILE 260.0194
GLU 270.0136
SER 280.0106
GLY 290.0207
PRO 300.0257
HIS 310.0125
CYS 320.0075
ALA 330.0140
ASN 340.0086
THR 350.0078
GLU 360.0135
ILE 370.0083
ILE 380.0103
VAL 390.0135
LYS 400.0127
LEU 410.0115
SER 420.0174
ASP 430.0151
GLY 440.0154
ARG 450.0126
GLU 460.0165
LEU 470.0093
CYS 480.0171
LEU 490.0064
ASP 500.0080
PRO 510.0092
LYS 520.0110
GLU 530.0154
ASN 540.0112
TRP 550.0114
VAL 560.0104
GLN 570.0161
ARG 580.0173
VAL 590.0105
VAL 600.0073
GLU 610.0056
LYS 620.0123
PHE 630.0066
LEU 640.0080
LYS 650.0221
ARG 660.0232
ALA 670.0446
GLU 680.0067
ASN 690.0175

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.